We further analyzed whether the serum concentrations of IL17 and IL10 were associated with tumor clinicopathological factors that were generally accepted as indicators of higher risk for HCC recurrence, including tumor size, tumor multinodularity, presence of microvascular invasion, lower grading of the tumor, and high serum level of AFP. Here, IL10 is linked to hepatocellular carcinoma.